Table 2.
Participants’ clinical characteristics and blood pressure level
| Characteristics | N (182) | % |
|---|---|---|
| CKD stage | ||
| Stage 3 (30-59 ml/min/1.73m2) | 102 | 56 |
| Stage 4 (15-29 ml/min/1.73m2) | 52 | 28.6 |
| Stage 5 (<15 ml/min/1.73m2) | 28 | 15.4 |
| Diabetes | ||
| No | 120 | 65.9 |
| Yes | 62 | 34.1 |
| Diabetes with CKD | ||
| No diabetes with CKD | 120 | 65.9 |
| Diabetes with CKD stage 3 | 49 | 26.9 |
| Diabetes with CKD stage 4 | 8 | 4.4 |
| Diabetes with CKD stage 5 | 5 | 2.8 |
| Comorbidity severity | ||
| Mild | 78 | 42.9 |
| Moderate | 48 | 26.3 |
| Severe | 56 | 30.8 |
| Comorbidities † | ||
| Diabetes with end-organ damage | 60 | 33 |
| Ischemic heart disease | 16 | 8.8 |
| Heart failure | 14 | 7.7 |
| Othersǂ | 5 | 2.7 |
| Perceived the importance of blood pressure control | ||
| Yes | 151 | 83 |
| No | 2 | 1.1 |
| Unknown | 29 | 15.9 |
| Known target blood pressure | ||
| Yes | 60 | 33 |
| No | 122 | 67 |
| Overall systolic blood pressure | ||
| Mean=138.3, SD=19.46, range=62-176 | ||
| Controlled systolic blood pressure (<130 mmHg) | 67 | 36.8 |
| <120 | 25 | 37.3 |
| 120-129 | 42 | 62.7 |
| (Mean=118.3, SD=12.07, range=62-129) | ||
| Uncontrolled systolic blood pressure (≥130 mmHg) | 115 | 63.2 |
| 130-139 | 28 | 24.3 |
| ≥140 | 87 | 75.7 |
| (Mean=149.9, SD=12.19, range=131-176) | ||
†
Comorbidities listed in Charlson Comorbidity Index;
ǂ
Chronic obstructive pulmonary disease, Diabetes, Peptic ulcer, Peripheral vascular disease, Cerebrovascular disease, Connective tissue disease, Mild liver disease, Hemiplegia, Any tumor, Leukemia, Lymphoma, Moderate or severe liver disease, AIDS.